Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Ready Capital
RC
$195M
| – | – |
-245,106
| Closed | -$397K | – |
|
3327
Red Cat Holdings
RCAT
$750M
| – | – |
-452,394
| Closed | -$5.92M | – |
|
3328
Radian Group
RDN
$4.63B
| – | – |
-827,456
| Closed | -$27.4M | – |
|
3329
Redwire
RDW
$2.25B
| – | – |
-93,736
| Closed | -$1.24M | – |
|
3330
REX American Resources
REX
$1.29B
| – | – |
-19,626
| Closed | -$894K | – |
|
3331
Rexford Industrial Realty
REXR
$7.88B
| – | – |
-1,307,136
| Closed | -$42.8M | – |
|
3332
Regions Financial
RF
$24.2B
| – | – |
-35,173
| Closed | -$919K | – |
|
3333
Sturm, Ruger & Co
RGR
$741M
| – | – |
-21,195
| Closed | -$850K | – |
|
3334
PUT
RH
RH
$2.75B
| – | – |
-16,600
| Closed | -$2.32M | – |
|
3335
Ryman Hospitality Properties
RHP
$9.14B
| – | – |
-409,959
| Closed | -$45.5M | – |
|
3336
Rallybio
RLYB
$86.1M
| – | – |
-376,573
| Closed | -$3.38M | – |
|
3337
PUT
Ross Stores
ROST
$72.8B
| – | – |
-27,700
| Closed | -$6M | – |
|
3338
Range Resources
RRC
$13.1B
| – | – |
-13,664
| Closed | -$617K | – |
|
3339
RUM Group Inc
RUM
$2.31B
| – | – |
-43,414
| Closed | -$221K | – |
|
3340
Revolution Medicines
RVMD
$40.4B
| – | – |
-23,799
| Closed | -$3.48M | – |
|
3341
Rhythm Pharmaceuticals
RYTM
$6.33B
| – | – |
-52,967
| Closed | -$4.61M | – |
|
3342
Sabre
SABR
$646M
| – | – |
-217,343
| Closed | -$315K | – |
|
|
3343
PUT
Sabre
SABR
$646M
| – | – |
-957,500
| Closed | -$1.39M | – |
|
3344
Safehold
SAFE
$777M
| – | – |
-244,151
| Closed | -$3.3M | – |
|
3345
Sonic Automotive
SAH
$2.01B
| – | – |
-109,094
| Closed | -$7.48M | – |
|
3346
CALL
Banco Santander
SAN
$169B
| – | – |
-450,000
| Closed | -$5.08M | – |
|
3347
Sana Biotechnology
SANA
$787M
| – | – |
-1,033,804
| Closed | -$2.98M | – |
|
3348
SAP
SAP
$273B
| – | – |
-2,800
| Closed | -$478K | – |
|
|
3349
PUT
SAP
SAP
$273B
| – | – |
-5,100
| Closed | -$873K | – |
|
3350
Stepan Co
SCL
$1.56B
| – | – |
-14,510
| Closed | -$725K | – |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.